Articles
-
Due to Complex Barriers, the Overwhelming Majority of Alzheimer’s Patients Do Not Participate in Clinical Trials
Improving clinical trial access and participation in Alzheimer’s disease trials could accelerate therapeutics to benefit the 1 in 10 Americans over age 65 who suffer from the condition.
Categorized in -
How to Ensure COVID-19 Doesn’t Delay Value-Based Care
The authors suggest supporting the adoption and existence of ACOs and preventing the loss of value-based opportunities via private equity or large hospital network acquisitions.
Categorized in -
Yes, We Need a Vaccine to Control COVID-19. But We Need New Treatments, Too.
New treatments for Covid-19 are needed before a vaccine is ready and as the essential backstop to manage it afterward, since vaccines aren’t perfect.
Categorized in -
The Need To More Effectively Regulate END Markets: A Primary Public Health Lesson of the US Vaping Associated Lung Injury Outbreak
The designation of END products as “tobacco products” rather than “medical products” in August 2016 meant manufacturers did not have to meet pharmaceutical safety standards; instead, minimal product safety regulations were imposed.
Categorized in -
COVID-19 is Exacerbating Challenges for Individuals with Addiction
The COVID-19 pandemic is adversely affecting efforts to control substance abuse according to Assistant Secretary of Health Admiral Brett P. Giroir, MD, who spoke with Rosalie Liccardo Pacula and Adam Leventhal.
-
New Digital Health Project Will Include Traditionally Underrepresented Americans
Ritika Chaturvedi will lead the American Life in Real-time (ALiR) project, which will use digital technologies to create precision public health interventions that focus on reducing health disparities.
-
Other Diseases Could Surge as Vaccination Rates Fall 87% for California Kids
As the coronavirus pandemic continues, parents put off or cancel their kids’ health appointments.
Categorized in -
California Must Quickly Implement Policies for Tracking and Controlling Health Care Costs and Price Increases
To protect Californians from rising health care costs, the state needs to strengthen price transparency and price competition, according to Melnick.
Categorized in -
Ten Actions For Better Post-Pandemic Healthcare In The United States
What changes should be made now to the U.S. healthcare system to make it better when things return to a new normal, and, in the event of future pandemics.
Categorized in -
Two Years After Launch, Biosimilars for Rheumatoid Arthritis and Other Lifelong Conditions Captured Little Market Share
While many experts believe biosimilars have the potential to lower drug costs through competitive pressure, adoption has been slower than some expected.
Categorized in